Delay of alternative antiviral therapy and poor outcomes of acyclovir ‐resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant – a retrospective study
Transplant International, EarlyView.
Source: Transplant International - Category: Transplant Surgery Source Type: research
More News: Acyclovir | Antiviral Therapy | Cold Sores | Herpes | Stem Cell Therapy | Stem Cells | Study | Transplants | Zovirax